Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2693-2024Class II

IBA Proton Therapy System - PROTEUS 235- Designed to produce and deliver a proton beam for the treatment of...

Ion Beam Applications S.A. / initiated 2024-07-10 / Open, Classified / root cause: manufacturing process

Ion Beam Applications S.A. began a recall of IBA Proton Therapy System - PROTEUS 235- Designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions... on . FDA classified it as Class II and gives the reason as "Temporary deactivation of collision detection for Forte Robotic Patient Positioning System occasionally experiences issues". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2693-2024
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Ion Beam Applications S.A.
Product
IBA Proton Therapy System - PROTEUS 235- Designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation
Product code
LHN System, Radiation Therapy, Charged-Particle, Medical
Reason for recall
Temporary deactivation of collision detection for Forte Robotic Patient Positioning System occasionally experiences issues
Root cause tag
manufacturing process
FDA root cause
Process design
Action
IBA isued Urgent Medical Device Correction letter on July 10, 2024. Letter states reason for recall, health risk and action to take: IBA would like to remind you as IBA Proton Therapy System -PROTEUS 235 user of the warnings present in your Clinical User's Guide which emphasize the importance of carefully monitoring the patients behavior during the different treatment phases. IBA would like to also remind you that the manual hand crank could be used by the system operator for the emergency release of the Patient Positioning System in the situations listed in the Clinical User's Guide and Accelerator Operator's Guide and by following the instructions described in both guides. To be signed and given back to IBA representative on site. PTS-8, PTS-10 and PTS-11 versions: Software upgrade IBA will update the software of the Positioning Management System in order that, after a collision, the request to temporarily disable the collision detection will be sent until the status of the collision detection is well disabled. This solution will be deployed at your site by March 2026. PTS-12 versions: users training and labeling change IBA will provide customer training on the system behavior in PTS-12 versions following collision detections. Additionally, IBA will update the labeling to clarify that users can also move the snout or gantry to go out collision situations. These solutions will be deployed at your site by January 2025
Quantity in commerce
19 units
Distribution
IL,LA, NJ, MI,OK, TN, TX, VA, WA Foreign: Czech Republic France Germany Italy Japan Poland Russia Sweden
Product codes and lots
UDI-DI: (01)05404013801138 Serial Numbers; PAT.108 (US), PAT.110 (US), PAT.111 (FR), PAT.112 (US), PAT.113 (US), PAT.114 (CZ), PAT.115 (IT), SAT.116 (US), SAT.117 (PL), SAT.118 (RU), SAT.119 (US), SAT.120 (DE), SAT.122 (SE), SAT.123 (US), SAT.126 (US), SBF.101 (FR), SBF.103 (JP), SBF.104 (JP), SBF.105(US).

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2693-2024
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2693-2024Class IIOngoingVoluntary: Firm initiated